SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors show strong conviction in its proprietary Alpha DaRT oncology platform, bolstered by recent Japanese marketing approval and upcoming trial milestones. The community is actively discussing the stock's robust cash position, the absence of dilution risk, and the belief that the company is significantly undervalued as it transitions into a commercial-stage player.

Praetorian Acquisition Corp. - Ordinary Shares - Class A

Investors are closely monitoring Praetorian Acquisition Corp. following its recent public debut as the market evaluates the potential for future merger and acquisition activity from the newly formed blank check company.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending as investors react to a 31.5% stake acquisition of Distributed Technologies Research, a move that has fueled intense community debate over potential dilution versus strategic expansion into AI-driven finance. Traders are also closely watching the ticker's high beta to Bitcoin, with many speculating on upcoming announcements at the company's investor day as they weigh the stock's long-term potential against past patterns of volatility.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending as investors react to the recent appointment of a new CFO and continued speculation regarding a potential hyperscaler tenant for its data center campus. Community discourse remains divided, with supporters highlighting upcoming catalysts and infrastructure scale, while skeptics point to the lack of official contract announcements and concerns over the company's delivery timeline.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is trending as investors weigh its aggressive pivot toward private credit and AI-driven infrastructure against lingering concerns regarding industry-wide redemption pressures and valuation risks in the real estate sector. The community is sharply divided, with some betting on a long-term turnaround fueled by record dry powder and strategic deployment, while others are closely monitoring potential liquidity constraints that could signal broader credit cycle risks.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is currently seeing significant momentum as investors digest its latest quarterly results, which showcased accelerating revenue growth and improved margins that suggest its AI-driven model is gaining traction. The stock remains a focal point for the retail community, who are actively debating its valuation versus its disruptive potential, while some traders continue to monitor for short-squeeze opportunities driven by high short interest and institutional interest.

Rydex Investments - Invesco CurrencyShares Canadian Dollar Trust

Invesco CurrencyShares Canadian Dollar Trust

The Canadian dollar is experiencing heightened volatility as investors weigh persistent trade-policy uncertainties and fluctuating crude oil prices against the Bank of Canada's cautious interest rate approach. The community is actively debating the potential for further easing, keeping a close watch on how shifting trade relations and economic data impact the currency's near-term trajectory.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is experiencing significant market interest following a strong quarterly earnings report that featured a double beat on top and bottom-line expectations and raised forward-looking guidance. The community is actively discussing the stock's impressive post-earnings price surge, debating the sustainability of its robotic surgery market dominance against potential margin pressures from tariffs and broader sector volatility.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently facing downward pressure as investors pivot away from safe-haven assets due to rising inflation fears and supply-side concerns triggered by the ongoing conflict in the Middle East. The community is actively debating whether current bond valuations offer a defensive hedge or if the broader economic strain from elevated energy costs and fiscal uncertainty will drive yields significantly higher.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors weigh recent legal escalations against competitive rivals alongside ongoing anticipation for federal integration pilot program updates and potential defense contract awards. Community sentiment remains deeply divided, balancing concerns over high cash burn and development delays against optimism for the stock's long-term positioning in the electric aviation sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Catheter Precision had initially acquired a 20% stake in Flyte in February before buying out the remaining 80% earlier on Tuesday.</li><li>Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK, making it a significant shareholder.</li><li>Earlier this month, Catheter Precision signed an agreement to raise about $1.9 million through a private placement.</li></ul>Shares of Catheter Precision (VTAK) jumped 50% on Tuesday after the company announced it had completed the acquisition of Fly Flyte, having bought out an 80% stake from Creatd.Flyte runs regional aviation services using Cirrus Vision Jets on short-haul routes where commercial airline service is limited or unavailable. It generates revenue through aircraft equipped with advanced safety systems such as whole-aircraft parachute technology and Safe Return autonomous landing capability.<h2 class="st-heading-2">Creatd To Receive $6M In Cash, $6M In Convertible Preferred Stock</h2>As part of the transaction, Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK. The two companies will collaborate on developing an aviation and Electric Vertical Take-Off and Landing (eVTOL) logistics platform.The deal makes Creatd a significant shareholder in VTAK, while it continues to pursue its plan to secure a national exchange listing later this year.Catheter Precision had initially acquired a 20% stake in Flyte in February, stating that the investment provides immediate exposure to the fast-growing private aviation sector and supports an asset-backed, scalable fleet expansion model.<h2 class="st-heading-2">Fundraising Worth Around $1.9 Million</h2>Earlier this month, Catheter Precision signed a securities purchase agreement with investors to raise about $1.9 million through a private placement of Series C-1 Convertible Preferred Stock, according to an SEC filing. The shares can initially convert into up to 1.3 million common shares at a conversion price of $1.43 per share.Investors also agreed to purchase additional Series C-2 and Series C-3 convertible preferred shares. The company plans to use the proceeds for working capital, restructuring its legacy catheter business, resolving liabilities, and reducing operating expenses.This came after the company completed a strategic financing deal with institutional investors worth up to $36.5 million last month.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/VTAK">VTAK</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/VTAK_jpg_6ed250b1a0.webp" alt="VTAK.jpg">One user expects the momentum to push the stock to $3 from its current price of around $2.<stembedurl>https://stocktwits.com/LosersMakeMillions/message/647117481</stembedurl>Another user said that since the revenue is “asset-backed,” it will grow when new jets are added to the service.<stembedurl>https://stocktwits.com/bachsong/message/647102061</stembedurl>VTAK shares have gained around 10% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/polymarket-pltr-stock-palantir-crackdown-insider-trading-sports-betting/cZdopaXRI7R">Polymarket Ropes In Palantir To Track Suspicious Sports Prediction Bets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

This Nano-Cap Medical Device Stock Soared 50% Today – What’s The Aviation Connection?

Catheter Precision completed the acquisition of Fly Flyte from Creatd, giving it access to the fast-growing private aviation sector.

VTAK Stock Jumps 50% Today – What’s Driving The Super Rally?

Equity

Strategic Partnerships and Platform Plays Power New Momentum Across Tech and Healthcare

Markets open the session with strategic partnerships, infrastructure consolidation, and breakthrough technologies dominating the corporate news cycle; several companies are positioning themselves at the intersection of innovation and scalable commercialization. $INKT, $VTAK, $KBLB, $APP, $BEAT, $SGN, $STGW

Medical device company Catheter Precision, Inc. (VTAK) announced on Monday that it has received approval for its suture retention device LockeT in the United Kingdom.LockeT is intended to assist in wound closure after percutaneous venous punctures or procedures involving the insertion of a needle through the skin to access the vein, including for the insertion of catheters. LockeT <a target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=4827478167656712&amp;symbol=VTAK">received</a> CE Mark for European approval and distribution in May 2025, but had to obtain registration to launch sales in the U.K. CE marking indicates a product's compliance with European Union (EU) safety, health, and environmental protection standards, allowing it to be sold freely within the European Economic Area (EEA).On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VTAK">Catheter Precision</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:627/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_at_12_40_56_PM_png_d31ad45d5e.webp" alt="VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits" width="627" height="58"><figcaption>VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they are entering a short position in the stock.<stembedurl>https://stocktwits.com/athebeast/message/625634169</stembedurl>Catheter Precision said it has partnered with HC21, a U.K.-based distributor, to distribute LockeT. Fatih Ayoglu, Sales Manager EMEA and APAC, said that the device’s intuitive design and ease of deployment enable earlier discharge following cardiac procedures.“This directly supports NHS efforts to reduce waiting lists by freeing up hospital capacity and accelerating patient throughput. With the NHS recently achieving its first reduction in waiting lists in 17 years, LockeT is poised to contribute meaningfully to this momentum by helping clinicians deliver more treatments, more efficiently,” Ayoglu added.VTAK stock is down by 56% this year and by about 91% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/vanda-pharma-stock-rallies-after-federal-appeals-court-sets-aside-fda-action/chsOi7vRdXQ">Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did Catheter Precision Stock Soar 49% Today?

The company’s product LockeT, which bagged approval in the U.K., had received CE Mark for European approval and distribution in May 2025.

Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins on September 4, 2002 and is headquartered in Fort Mill, SC.

VTAK
Catheter Precision Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VTAK News

VTAKCatheter Precision Inc.